Abstract:In our continuing search for novel small-molecule anticancer agents, we designed and synthesized a series of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides (5), focusing on the modification of substitution in the quinazolin-4(3H)-one moiety. The biological evaluation showed that all 13 designed and synthesized compounds displayed significant cytotoxicity against three human cancer cell lines (SW620, colon cancer; PC-3, prostate cancer; NCI-H23, lung cancer). The most potent compound 5l displayed cytotoxicity up to 213-fold more potent than 5-fluorouracil and 87-fold more potent than PAC-1, the first procaspase-activating compound. Structure-activity relationship analysis revealed that substitution of either electron-withdrawing or electron-releasing groups at positions 6 or 7 on the quinazolin-4(3H)-4-one moiety increased the cytotoxicity of the compounds, but substitution at position 6 seemed to be more favorable. In the caspase activation assay, compound 5l was found to activate the caspase activity by 291% in comparison to PAC-1, which was used as a control. Further docking simulation also revealed that this compound may be a potent allosteric inhibitor of procaspase-3 through chelation of the inhibitory zinc ion. Physicochemical and ADMET calculations for 5l provided useful information of its suitable absorption profile and some toxicological effects that need further optimization to be developed as a promising anticancer agent.

One-Pot Three-Component Synthesis of Novel Diethyl((2-oxo-1,2-dihydroquinolin-3-yl)(arylamino)methyl)phosphonate As Potential Anticancer Agents.

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Design, Synthesis, and Evaluation of New 2-Oxoquinoline Arylaminothiazole Derivatives As Potential Anticancer Agents.

Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Acrylamide

Synthesis and Structure-Activity Relationships Study of Α -Aminophosphonate Derivatives Containing a Quinoline Moiety

Synthesis and Antitumor Activity of Α-Aminophosphonate Derivatives Containing Thieno[2,3-D]pyrimidines

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis and Antitumor Activity of Novel 4-Aminoquinazoline Derivatives Containing Benzothiazole

Synthesis and antitumor activity evaluation in vitro of 4-aminoquinazoline derivatives containing 1,3,4-thiadiazole

[Design, Synthesis and Antitumor Activities of Novel E-substituted 2,3-Diaryl Propenoic Acyloxy Phosphonate Derivatives].

Synthesis, in Vitro and in Vivo Evaluation of Novel Substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines As Potent Antitumor Agents.

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives

Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents

Design, synthesis and anti-tumor activity evaluation of 4,6,7-substitute quinazoline derivatives

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Design and Synthesis of 6,7-Methylenedioxy-4-substituted Phenylquinolin-2(1H)-one Derivatives As Novel Anticancer Agents That Induce Apoptosis with Cell Cycle Arrest at G2/M Phase

The synthesis and anti-tumor activity research of a novel quinazoline derivatives

Design, Synthesis, Structure-Activity Relationships and Mechanism of Action of New Quinoline Derivatives As Potential Antitumor Agents

Novel Penta-1,4-Diene-3-One Derivatives Containing Quinazoline And Oxime Ether Fragments: Design, Synthesis And Bioactivity

Synthesis of Novel Nucleoside Analogue Phosphorothioamidate Prodrugs and in Vitro Anticancer Evaluation Against RKO Human Colon Carcinoma Cells

Design, Synthesis and Antiproliferative Activity of Novel 5-Nitropyrimidine-2,4-diamine Derivatives Bearing Alkyl Acetate Moiety